Ansell Limited
Ansell Limited
- P/E ratio
- 20.81
Your view on ANN.AX
Overview
What the company does, where it operates, and who runs it.
About Ansell Limited
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Nathalie Ahlstrom
- Headquarters
- 678 Victoria Street, Richmond, VIC, AU
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Nathalie Ahlstrom
- Headquarters
- 678 Victoria Street, Richmond, VIC, AU
Ansell Limited is a global enterprise that conceptualizes, innovates, and produces protective equipment for various industries across numerous regions, including Asia Pacific, Europe, the Middle East, Africa, the Americas, and the Caribbean. The company's operations are divided into two principal divisions: Healthcare and Industrial.
The Healthcare division focuses on crafting and distributing products such as surgical, single-use, and examination gloves, alongside specialized cleanroom and sterile gloves and apparel.
These offerings cater to a diverse clientele including medical facilities, surgical clinics, dental offices, veterinary practices, emergency services, research laboratories, and pharmaceutical and life science firms.
Conversely, the Industrial segment provides hand and chemical protective gear designed for a wide array of demanding applications, from the automotive, chemical, and metal fabrication sectors to machinery, food processing, construction, mining, oil and gas industries, and first responders.
Established in 1893 and headquartered in Richmond, Australia, the company was initially known as Pacific Dunlop Limited before rebranding to Ansell Limited in 2002. P. D. Holdings Pty. Ltd. currently operates as a subsidiary of Ansell Limited.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Ansell Limited from FRC's valuation model, read against the market price. ANN.AX last traded at AUD 34.67, 20.8× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Ansell Limited. Starting points for Ansell Limited: P/E 20.8, EPS AUD 1.47, beta 0.56 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Ansell Limited. Ansell Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Ansell Limited. Trailing twelve-month EPS for Ansell Limited stands at AUD 1.47. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterSep 2025 | Next quarterDec 2025 | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|---|---|
| Average estimate | $0.00 | $0.64 | $1.71 | $1.83 |
| Lowest estimate | $0.00 | $0.64 | $1.65 | $1.76 |
| Highest estimate | $0.00 | $0.64 | $1.73 | $1.91 |
| Number of analysts | 0 | 1 | 8 | 8 |
| A year ago | $0.841 | $1.131 | $1.481 | — |
| Growth vs a year ago | — | — | — | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterSep 2025 | Next quarterDec 2025 | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|---|---|
| Average estimate | $1.02B | $1.09B | $2.32B | $2.41B |
| Lowest estimate | $1.02B | $1.09B | $2.27B | $2.34B |
| Highest estimate | $1.02B | $1.09B | $2.36B | $2.47B |
| Number of analysts | 1 | 1 | 11 | 11 |
| A year ago | $1.01B | $942.90M | $2.19B | — |
| Growth vs a year ago | +1.1% | +15.5% | +6.2% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Ansell Limited. Ansell Limited has reported as a listed company since 1988. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| AHC.AXAustco Healthcare Limited | Healthcare | Medical - Instruments & Supplies | — | ||
| NAN.AXNanosonics Limited | Healthcare | Medical - Instruments & Supplies | — | ||
| TRJ.AXTrajan Group Holdings Limited | Healthcare | Medical - Instruments & Supplies | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| STVNStevanato Group S.p.A. | Healthcare | NYSE | $4.3B | ||
| STXSStereotaxis, Inc. | Healthcare | AMEX | $95.0M | ||
| SUVPFSartorius AG | Healthcare | OTC | $18.7B | ||
| SVSOSheerVision, Inc. | Healthcare | OTC | $2,551 | ||
| TCGGYTecan Group AG | Healthcare | OTC | $2.3B | ||
| TCHBFTecan Group AG | Healthcare | OTC | $2.2B | ||
| TDVXFTobii Dynavox AB (publ) | Healthcare | OTC | $981.6M | ||
| TFXTeleflex Incorporated | Healthcare | NYSE | $6.4B | ||
| TGLVYTop Glove Corporation Bhd. | Healthcare | OTC | $1.1B | ||
| TRUMFTerumo Corporation | Healthcare | OTC | $18.9B | ||
| TRUMYTerumo Corporation | Healthcare | OTC | $19.5B | ||
| Ticker | Fund | Fund assets | % of the fund |
|---|---|---|---|
| VXUSVanguard Total International Stock ETF | $163.2B in assets | 0.01% | |
| VEAVanguard FTSE Developed Markets ETF | $231.6B in assets | 0.01% | |
| IEFAiShares Core MSCI EAFE ETF | $188.8B in assets | 0.02% | |
| SPDWState Street SPDR Portfolio Developed World ex-US ETF | $41.0B in assets | 0.05% | |
| JPINJPMorgan Diversified Return International Equity ETF | $388M in assets | 0.31% | |
| FNDCSchwab Fundamental International Small Equity ETF | $3.0B in assets | 0.13% | |
| DFISDimensional - International Small Cap ETF | $5.8B in assets | 0.13% | |
| IPACiShares Core MSCI Pacific ETF | $2.6B in assets | 0.05% | |
Largest holders first, then the funds most concentrated in ANN.AX.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Ansell Limited. Coverage tracks Ansell Limited within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Ansell Limited.